CCL17 and chronic kidney disease: In our study we provided a hypothesis that CCL17 has pro-fibrogenetic effects by demonstrating that its overexpression increases of phenotype transformation and motility in renal tubule epithelial cells and ECM accumulation in vitro and in vivo as well as being clinically useful as a novel biomarker that correlates negatively with renal function in CKD patients.